GILD - Gilead invests $200M in Arcellx as collaboration expands
2023-11-15 06:39:59 ET
More on Arcellx
- Arcellx: Clinical Hold Lifted, Charting A Brighter Path Forward (Rating Upgrade)
- Arcellx jumps after data for Gilead-partnered multiple myeloma drug
- Seeking Alpha’s Quant Rating on Arcellx
- Historical earnings data for Arcellx
- Financial information for Arcellx
For further details see:
Gilead invests $200M in Arcellx as collaboration expands